PubRank

A M Tonkin

Author PubWeight™ 73.50‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Chronic heart failure in Australian general practice. The Cardiac Awareness Survey and Evaluation (CASE) Study. Med J Aust 2001 2.71
2 Apo B versus cholesterol in estimating cardiovascular risk and in guiding therapy: report of the thirty-person/ten-country panel. J Intern Med 2006 2.55
3 Pravastatin therapy and the risk of stroke. N Engl J Med 2000 2.46
4 Application of the Poincaré plot to heart rate variability: a new measure of functional status in heart failure. Aust N Z J Med 1995 2.21
5 Continuous relationships between non-diabetic hyperglycaemia and both cardiovascular disease and all-cause mortality: the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study. Diabetologia 2009 1.85
6 Validity of self-reported cardiovascular disease events in comparison to medical record adjudication and a statewide hospital morbidity database: the AusDiab study. Intern Med J 2009 1.81
7 Atrial fibrillation after coronary artery bypass grafting is associated with sympathetic activation. Ann Thorac Surg 1995 1.75
8 Passive ventricular constraint amends the course of heart failure: a study in an ovine model of dilated cardiomyopathy. Cardiovasc Res 1999 1.65
9 Comparison of dobutamine echocardiography and positron emission tomography in patients with chronic ischemic left ventricular dysfunction. J Am Coll Cardiol 1996 1.61
10 Poincaré plot of heart rate variability allows quantitative display of parasympathetic nervous activity in humans. Clin Sci (Lond) 1996 1.60
11 Effect of pravastatin on coronary disease events in subgroups defined by coronary risk factors: the Prospective Pravastatin Pooling Project. Circulation 2000 1.51
12 The PACE pilot study: 12-month results and implications for future primary prevention trials in the elderly. (Prevention with low-dose Aspirin of Cardiovascular disease in the Elderly) J Am Geriatr Soc 1994 1.45
13 Reflex and mechanical circulatory effects of graded Valsalva maneuvers in normal man. J Appl Physiol 1976 1.42
14 Cardiovascular disease at the turn of the century. Med J Aust 1999 1.39
15 Cost effectiveness of radiofrequency catheter ablation in the treatment of symptomatic supraventricular tachyarrhythmias. Aust N Z J Med 1993 1.39
16 Proximal aortic atheroma. An independent risk factor for cerebral ischemia. Stroke 1995 1.24
17 The metabolic syndrome as a tool for predicting future diabetes: the AusDiab study. J Intern Med 2008 1.16
18 Adverse effects of low-dose aspirin in a healthy elderly population. Clin Pharmacol Ther 1993 1.12
19 Evidence that patent foramen ovale is not a risk factor for cerebral ischemia in the elderly. Am J Cardiol 1994 1.01
20 Coexistence of functional Kent and Mahaim-type tracts in the pre-excitation syndrome. Demonstration by catheter techniques and epicardial mapping. Circulation 1975 1.01
21 Ventriculo-atrial conduction time during reciprocating tachycardia with intermittent bundle-branch block in Wolff-Parkinson-White syndrome. Br Heart J 1976 0.99
22 HOMA insulin sensitivity index and the risk of all-cause mortality and cardiovascular disease events in the general population: the Australian Diabetes, Obesity and Lifestyle Study (AusDiab) study. Diabetologia 2009 0.95
23 The intraoperative assessment of ascending aortic atheroma: epiaortic imaging is superior to both transesophageal echocardiography and direct palpation. J Cardiothorac Vasc Anesth 1997 0.94
24 Comparison of recruitment strategies for a large-scale clinical trial in the elderly. J Clin Epidemiol 1991 0.92
25 Pattern and significance of cerebral microemboli during coronary artery bypass grafting. Ann Thorac Surg 1998 0.91
26 Large animal models of heart failure. Aust N Z J Med 1999 0.90
27 New catheter techniques for analysis of the sequence of retrograde atrial activation in man. Eur J Cardiol 1978 0.89
28 Persistence of MB isoenzyme of creatine phosphokinase in the serum after minor iatrogenic cardiac trauma. Absence of postmortem evidence of myocardial infarction. Circulation 1975 0.89
29 Unusual hepatocellular and cardiovascular complications of disopyramide. Chest 1980 0.88
30 Susceptibility to atrial fibrillation: a study in an ovine model of pacing-induced early heart failure. J Cardiovasc Electrophysiol 1998 0.88
31 Leptin, but not adiponectin, is a predictor of recurrent cardiovascular events in men: results from the LIPID study. Int J Obes (Lond) 2008 0.87
32 Procainamide administration during electrophysiology study--utility as a provocative test for intermittent atrioventricular block. Pacing Clin Electrophysiol 1988 0.87
33 Atrial and His bundle stimulation with an accessory nodo-ventricular connection. Pacing Clin Electrophysiol 1980 0.87
34 Plasma atrial natriuretic polypeptide concentrations during and after reversion of paroxysmal supraventricular tachycardias. Br Heart J 1988 0.87
35 Atrial fibrillation with left atrial spontaneous contrast detected by transesophageal echocardiography is a potent risk factor for stroke. Am J Cardiol 1996 0.87
36 Intermittent atrioventricular block: procainamide administration as a provocative test. Aust N Z J Med 1978 0.85
37 Determination of debrisoquine and its 4-hydroxy metabolite in urine by high-performance liquid chromatography. J Chromatogr 1986 0.84
38 Determination of 4-amino-3-(p-chlorophenyl)butyric acid (baclofen) in plasma by high-performance liquid chromatography. J Chromatogr 1985 0.84
39 Failure of current public educational campaigns to impact on the initial response of patients with possible heart attack. Intern Med J 2005 0.84
40 Initial forces of ventricular depolarization in the Wolff-Parkinson-White Syndrome. Analysis based upon localization of the accessory pathway by epicardial mapping. Circulation 1975 0.84
41 A placebo-controlled trial verifying the efficacy of milrinone in weaning high-risk patients from cardiopulmonary bypass. J Cardiothorac Vasc Anesth 1997 0.84
42 Retrograde atrial preexcitation following premature ventricular beats during reciprocating tachycardia in the Wolff-Parkinson-White syndrome. Eur J Cardiol 1976 0.84
43 Maximizing efficiency and cost-effectiveness of Type 2 diabetes screening: the AusDiab study. Diabet Med 2011 0.84
44 Cardiac tamponade in hydrallazine-induced systemic lupus erythematosus. Aust N Z J Med 1982 0.84
45 Effects of left atrial dilatation on the endocardial atrial defibrillation threshold: a study in an ovine model of pacing induced dilated cardiomyopathy. Pacing Clin Electrophysiol 1998 0.83
46 Morning increase in the time of onset of sustained ventricular tachycardia. Am J Cardiol 1989 0.83
47 Churg-Strauss syndrome, cardiac involvement and life threatening ventricular arrhythmias. Aust N Z J Med 1992 0.83
48 Severe acute haemolytic anaemia complicating infectious mononucleosis. Med J Aust 1973 0.82
49 Autonomic effects on the human cardiac conduction system. Evaluation by intracardiac electrocardiography and programmed stimulation techniques. Br Heart J 1980 0.82
50 Anterograde block in accessory pathways with retrograde conduction in reciprocating tachycardia. Eur J Cardiol 1975 0.82
51 Validation of an echocardiographic assessment of cardiac function following moderate size myocardial infarction in the rat. Clin Exp Pharmacol Physiol 1996 0.80
52 Ischaemic heart disease: across the social and geographic divides. Med J Aust 2000 0.80
53 Prediction of outcome after revascularization in patients with poor left ventricular function. Ann Thorac Surg 1996 0.79
54 Arterial hypoxaemia in acute myocardial infarction. Aust N Z J Med 1973 0.79
55 Rationale for a primary prevention study using low-dose aspirin to prevent coronary and cerebrovascular disease in the elderly. J Am Geriatr Soc 1991 0.79
56 Tachyarrhythmias in Wolff-Parkinson-White syndrome. Treatment and prevention. JAMA 1976 0.79
57 Refractory periods of the accessory pathway in the Wolff-Parkinson-White syndrome. Circulation 1975 0.78
58 Verapamil in prophylaxis of paroxysmal atrioventricular nodal reentrant tachycardia. J Cardiovasc Pharmacol 1980 0.78
59 Atrial fibrillation: epidemiology and the risk and prevention of stroke. Pacing Clin Electrophysiol 1992 0.78
60 Valsalva constrictor and heart rate reflexes in subjects with essential hypertension and with normal blood pressure. Clin Exp Pharmacol Physiol 1979 0.78
61 A randomized comparison of intravenous heparin with oral aspirin and dipyridamole 24 hours after recombinant tissue-type plasminogen activator for acute myocardial infarction. National Heart Foundation of Australia Coronary Thrombolysis Group. Circulation 1991 0.78
62 Importance of electrode design, lead configuration and impedance for successful low energy transcatheter atrial defibrillation in dogs. J Am Coll Cardiol 1993 0.78
63 Atrial natriuretic factor release during rapid ventricular pacing: interplay between autonomic and hemodynamic stimulants. Am Heart J 1993 0.77
64 Transoesophageal echocardiography in the investigation of stroke: experience in 135 patients with cerebral ischaemic events. Aust N Z J Med 1993 0.76
65 Valsalva vasoconstrictor reflex in human hypertension in after beta-adrenoreceptor blockade in conscious rabbits. Clin Sci Mol Med Suppl 1976 0.76
66 The antiarrhythmic effect of intravenous disopyramide in an open study. Aust N Z J Med 1982 0.76
67 Concentrations of plasma atrial natriuretic factor during and after reversion of ventricular tachycardia. Br Heart J 1990 0.75
68 Sinus node sequences after atrial stimulation: similarities of effects of different methods. Br Heart J 1985 0.75
69 Assessment of coronary artery disease by dobutamine stress echocardiography (DSE). Aust N Z J Med 1995 0.75
70 Catheter ablation and other options in patients with accessory pathways. Aust N Z J Med 1990 0.75
71 Low-dose but not high-dose captopril increases parasympathetic activity in patients with heart failure. J Cardiovasc Pharmacol 1997 0.75
72 Stable oral availability of sustained release propranolol when co-administered with hydralazine or food: evidence implicating substrate delivery rate as a determinant of presystemic drug interactions. Br J Clin Pharmacol 1984 0.75
73 Issues in extrapolating from clinical trials to clinical practice and outcomes. Aust N Z J Med 1998 0.75
74 Hemorrhagic myocardial infarction complicated by free wall-rupture: a case associated with unusual clinical features following intravenous thrombolytic therapy. Aust N Z J Med 1989 0.75
75 A mathematical model of sinus node function: validation by recording of sinus node electrograms. Am J Physiol 1994 0.75
76 Clinical implications of electrophysiology study findings in patients with chronic bifascicular block and syncope. Aust N Z J Med 1988 0.75
77 Ablation of conduction pathways: the need for caution. Aust N Z J Med 1984 0.75
78 Atrial pacing in ventricular tachycardia and supraventricular tachycardia with aberrant intraventricular conduction: diagnostic and therapeutic implications. Aust N Z J Med 1979 0.75
79 Dizziness and syncope in the elderly. Aust Fam Physician 1988 0.75
80 Transesophageal electrocardiography and atrial pacing in acute cardiac care: diagnostic and therapeutic value. Aust N Z J Med 1989 0.75
81 Arrhythmias and antiarrhythmic agents. Med J Aust 1984 0.75
82 Management of arrhythmias due to accessory conduction pathways. Pacing Clin Electrophysiol 1978 0.75
83 Low energy endocardial cardioversion of atrial arrhythmias in humans. Pacing Clin Electrophysiol 1995 0.75
84 Haematological profile of healthy elderly Australians. Med J Aust 1992 0.75
85 Current guidelines for the management of unstable angina: a new diagnostic and management paradigm. Intern Med J 2001 0.75
86 Development and validation of echocardiographic methods for estimating left ventricular mass in rats. Clin Exp Pharmacol Physiol 1992 0.75
87 New insights into the pathogenesis, prevention and management of acute coronary syndromes. Aust N Z J Med 1996 0.75
88 Evaluation of mitral valve repair by intraoperative transoesophageal echocardiography. Aust N Z J Med 1993 0.75
89 Mithramycin treatment of hypercalcaemia associated with malignancy. Med J Aust 1973 0.75
90 Rapid and simultaneous extraction of propranolol, its neutral and basic metabolites from plasma and assay by high-performance liquid chromatography. J Chromatogr 1985 0.75
91 Specific effects of zatebradine on sinus node function: suppression of automaticity, prolongation of sinoatrial conduction and pacemaker shift in the denervated canine heart. J Pharmacol Exp Ther 1995 0.75
92 Echocardiographic study of U wave inversion in the electrocardiograms of hypertensive patients. J Electrocardiol 1989 0.75
93 Determination of alpha-naphthoxylactic acid, a major metabolite of propranolol, in plasma by high-performance liquid chromatography. J Chromatogr 1986 0.75
94 Simple and rapid analysis of atenolol and metoprolol in plasma using solid-phase extraction and high-performance liquid chromatography. J Chromatogr 1985 0.75
95 Primary oxalosis with myocardial involvement and heart block. Med J Aust 1976 0.75
96 Association of sick sinus and Lown-Ganong-Levine syndromes. Aust N Z J Med 1978 0.75
97 Atrial fibrillation: the questions and controversies. P N G Med J 1990 0.75
98 Cardiovascular risk factors and mortality. Med J Aust 1988 0.75
99 Computer algorithm for modeling transmission over one or two conduction pathways through AV node. Am J Physiol 1988 0.75
100 Detection of jeopardised viable myocardium in patients with coronary artery disease. Med J Aust 1993 0.75
101 Congestive cardiac failure and arrhythmias. Med J Aust 1995 0.75
102 Ethical, medical and legal issues for the use of placebos in future lipid intervention trials. Curr Opin Lipidol 2001 0.75
103 The prophylaxis of AV nodal re-entry tachycardia. Clin Exp Pharmacol Physiol Suppl 1982 0.75
104 New approaches to the management of the Wolff-Parkinson-White syndrome. Aust N Z J Med 1976 0.75
105 [Investigation of the preexcitation syndromes]. Herz 1983 0.75
106 Assessment of idiopathic dilated cardiomyopathy using positron emission tomography (PET). Aust N Z J Med 1995 0.75
107 Electrophysiological testing of sinus node function. Pacing Clin Electrophysiol 1984 0.75
108 beta-Blockade in acute myocardial infarction. Inability of relatively late administration to influence infarct size and arrhythmias. Med J Aust 1981 0.75
109 Clinical electrophysiology study in patients with syncope of undetermined etiology. Aust N Z J Med 1987 0.75
110 Ventricular standstill despite normal electrophysiology study: a further possible indication for pacing. Aust N Z J Med 1983 0.75
111 Thrombolysis '93--overview and conclusions. Aust N Z J Med 1993 0.75
112 Appraisal of factors influencing the normal sinus node recovery time. Aust N Z J Med 1980 0.75
113 Fast algorithms for the analysis of sino-atrial node function. Int J Biomed Comput 1985 0.75
114 Programmed stimulation after anterior myocardial infarction complicated by bundle branch block--late ventricular tachyarrhythmias and outcome. Pacing Clin Electrophysiol 1988 0.75
115 Clinical effectiveness in everyday practice: improving outcomes for all patients through a national acute coronary syndrome data collaborative. Intern Med J 2011 0.75